0001556247-13-000003.txt : 20130826
0001556247-13-000003.hdr.sgml : 20130826
20130826102630
ACCESSION NUMBER: 0001556247-13-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130822
FILED AS OF DATE: 20130826
DATE AS OF CHANGE: 20130826
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RYAN ARTHUR F
CENTRAL INDEX KEY: 0001187443
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 131059532
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-08-22
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001187443
RYAN ARTHUR F
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
1
0
0
0
Common Stock
2013-08-22
4
M
0
5000.0
18.61
A
39855
D
Common Stock
2013-08-22
4
F
0
393.0
236.64
D
39462
D
Common Stock
2013-08-22
4
M
0
10000.0
24.41
A
49462
D
Common Stock
2013-08-22
4
F
0
1031.0
236.64
D
48431
D
Common Stock
2013-08-22
4
M
0
10000.0
33.42
A
58431
D
Common Stock
2013-08-22
4
F
0
1412.0
236.64
D
57019
D
Common Stock
2013-08-22
4
M
0
5000.0
57.11
A
62019
D
Common Stock
2013-08-22
4
F
0
1206.0
236.64
D
60813
D
Common Stock
2013-08-23
4
S
0
10958.0
238.47
D
49855
D
Non-Qualified Stock Option (right to buy)
18.61
2013-08-22
4
M
0
5000.0
D
2019-01-02
Common Stock
5000
0
D
Non-Qualified Stock Option (right to buy)
24.41
2013-08-22
4
M
0
10000.0
D
2020-01-04
Common Stock
10000
0
D
Non-Qualified Stock Option (right to buy)
33.42
2013-08-22
4
M
0
10000.0
D
2021-01-03
Common Stock
10000
5000
D
Non-Qualified Stock Option (right to buy)
57.11
2013-08-22
4
M
0
5000.0
D
2022-01-03
Common Stock
5000
10000
D
Represents volume-weighted average price of sales of 10,958 shares of Company stock on August 23, 2013 at prices ranging from $238.24 to $238.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2013 at each separate price.
The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Arthur F. Ryan
2013-08-24